Viewing StudyNCT00066768



Ignite Creation Date: 2024-05-05 @ 11:31 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00066768
Status: COMPLETED
Last Update Posted: 2013-06-04
First Post: 2003-08-06

Brief Title: Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer
Sponsor:
Organization: National Cancer Institute NCI